header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

S1101 THE EFFECT OF LOW-INTENSITY ULTRASOUND ON BONE HEALING IN NONUNIONS, AND OSTEOTOMIES



Abstract

Aims: Low-intensity pulsed ultrasound has shown acceleration of bone healing in fresh fractures. The goal of this study is to assess the effect of low-intensity ultrasound on bone healing in established nonunion cases and following osteotomy. Methods: A non randomized trial on 29 cases, located in the tibia, femur, radius/ulna, scaphoid, humerus, metatarsal and clavicle, met the criteria for established nonunions. On average, the post-fracture period prior to the start of ultrasound treatment was 61 weeks. Daily, twenty-minute applications of low-intensity ultrasound at the site of the non-union were performed by the patients at home. In a placebo-controlled, randomized clinical trial double-blinded trial, 97 adults, who had undergone an osteotomy of the lower extremity were randomly allocated an active- or placebo ultrasound device. Every two weeks the patients were examined both clinical and radiological. Results: Twenty-five of the twenty-nine non-union cases (86%) healed in an average treatment time of 22 weeks. Forty-six patients (75 bones) were treated with an active ultrasound device and 44 patients (78 bones) with a placebo device were eligible for analysis. An overall reduction of time to consolidation of 32% was established. A nonunion, which had to be treated operatively, occurred in four cases in the placebo group and in none in the active group. No other prognostic variables were found. Conclusions: Low-intensity ultrasound can stimulate bone healing in osteotomies and nonunions. In patients with a fracture or osteotomy, who are at high risk of developing nonunion, low-intensity ultrasound can be valuable as additional therapy.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.